SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > ImmunoCellular Therapeutics, Ltd. (IMUC)

totally agree with that

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
biomanbaba Member Profile
 Grandfathered Member
Followed By 203
Posts 14,251
Boards Moderated 1
Alias Born 02/04/01
160x600 placeholder
ImmunoCellular Therapeutics to Report Third Quarter 2017 Financial Results on November 21, 2017 "PR Newswire (US)" - 11/17/2017 6:00:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 11/15/2017 4:47:44 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/11/2017 8:32:29 AM
ImmunoCellular Therapeutics to Present at the Lytham Partners Virtual Investor Conference on October 11, 2017 at 2:00pm ET "PR Newswire (US)" - 10/3/2017 6:00:00 AM
ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its Plan of Compliance "PR Newswire (US)" - 9/13/2017 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/28/2017 4:32:17 PM
ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy "PR Newswire (US)" - 8/23/2017 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/17/2017 4:33:30 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/17/2017 4:18:12 PM
ImmunoCellular Therapeutics Announces Second Quarter 2017 Financial Results "PR Newswire (US)" - 8/14/2017 6:00:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/14/2017 5:27:29 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 7/31/2017 6:09:24 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/24/2017 4:32:22 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 4:32:40 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) "Edgar (US Regulatory)" - 7/20/2017 4:13:04 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 7/19/2017 12:08:45 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/18/2017 6:01:14 AM
ImmunoCellular Therapeutics Announces Pricing of Public Offering of Convertible Preferred Stock and Warrants "PR Newswire (US)" - 7/18/2017 6:00:00 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 7/13/2017 6:05:21 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 7/10/2017 6:04:14 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/29/2017 4:17:50 PM
ImmunoCellular Therapeutics Receives Notice from NYSE MKT for Noncompliance with Continued Listing Standards "PR Newswire (US)" - 6/29/2017 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/22/2017 4:17:36 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/21/2017 5:28:29 PM
ImmunoCellular Therapeutics Provides Update on Strategic Review and Decision to Suspend Further Patient Randomization for ICT... "PR Newswire (US)" - 6/21/2017 6:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist